Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-08

AUTHORS

Jyoti Velayudhan, Yuh-feng Chen, Amanda Rohrbach, Christina Pastula, Gwen Maher, Heather Thomas, Ryan Brown, Teresa L. Born

ABSTRACT

BACKGROUND: Due to the complex molecular structure and proprietary manufacturing processes of monoclonal antibodies (mAbs), differences in structure and function may be expected during development of biosimilar mAbs. Important regulatory requirements for approval of biosimilar products involve comprehensive assessments of any potential differences between proposed biosimilars and reference mAbs, including differences in all known mechanisms of action, using sensitive and relevant methods. Any identified structural differences should not result in differences in biofunctional or clinical activity. OBJECTIVE: A comprehensive assessment comparing the Amgen biosimilar candidate ABP 501 with FDA-licensed adalimumab (adalimumab [US]) and EU-authorized adalimumab (adalimumab [EU]) was conducted to demonstrate similarity in biofunctional activity. METHODS: The functional similarity assessment included testing of binding kinetics to soluble tumor necrosis factor α (TNFα) and relative binding to transmembrane TNFα. The neutralization of TNFα-induced caspase activation, TNFα- and lymphotoxin-α (LTα)-induced chemokine production, and cytotoxicity was also tested. Binding to Fc-gamma receptors FcγRIa, FcγRIIa (131H), FcγRIIIa (158V and 158F), and neonatal Fc receptor (FcRn) was compared with the reference mAbs, as was antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity. RESULTS: The data demonstrate that ABP 501 is similar to both adalimumab (US) and adalimumab (EU) with respect to evaluated biofunctional activities. CONCLUSION: Similarity in biofunctional activity is a critical component of the totality of evidence required for demonstration of biosimilarity. The functional similarity demonstrated for ABP 501 comprehensively assesses the known mechanisms of action of adalimumab, supporting the conclusion that ABP 501, adalimumab (US), and adalimumab (EU) are likely to be clinically similar. More... »

PAGES

339-351

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40259-016-0185-2

DOI

http://dx.doi.org/10.1007/s40259-016-0185-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042463549

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27422671


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adalimumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibody-Dependent Cell Cytotoxicity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biosimilar Pharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CHO Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cricetulus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Histocompatibility Antigens Class I", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphotoxin-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Fc", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, IgG", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surface Plasmon Resonance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Necrosis Factor-alpha", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Velayudhan", 
        "givenName": "Jyoti", 
        "id": "sg:person.01332245460.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332245460.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Yuh-feng", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rohrbach", 
        "givenName": "Amanda", 
        "id": "sg:person.010407272255.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010407272255.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pastula", 
        "givenName": "Christina", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maher", 
        "givenName": "Gwen", 
        "id": "sg:person.01367737005.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367737005.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thomas", 
        "givenName": "Heather", 
        "id": "sg:person.01307711153.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307711153.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brown", 
        "givenName": "Ryan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Born", 
        "givenName": "Teresa L.", 
        "id": "sg:person.014172554655.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014172554655.08"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.crohns.2014.02.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001979414"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/bs.s75573", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004115169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2014.10.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009055890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/abio.2001.5380", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010553021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.1003526", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011527870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd2804", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011803907", 
          "https://doi.org/10.1038/nrd2804"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-06-583617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011903836"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4236/abb.2013.44a004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022030812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ibd.20225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023972012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ibd.20225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023972012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ibd.20225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023972012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.biologicals.2014.05.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027312444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mib.0b013e318281333b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029263183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mib.0b013e318281333b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029263183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.jidsymp.5650034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038176817", 
          "https://doi.org/10.1038/sj.jidsymp.5650034"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40259-016-0184-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038300105", 
          "https://doi.org/10.1007/s40259-016-0184-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40259-016-0184-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038300105", 
          "https://doi.org/10.1007/s40259-016-0184-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1074-7613(00)80152-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040583975"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.23447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041038096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jaad.2016.02.972", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041679936"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2014-eular.2166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041998525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cyto.2008.11.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044711621"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pharmthera.2007.10.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045852057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/apt.12749", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046366682"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/rheumatology/keq031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046888240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/blr.2006.25.447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059238419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2015-208914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062759425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2015-208914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062759425"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2011.0136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078459400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2011.0136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078459400"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-08", 
    "datePublishedReg": "2016-08-01", 
    "description": "BACKGROUND: Due to the complex molecular structure and proprietary manufacturing processes of monoclonal antibodies (mAbs), differences in structure and function may be expected during development of biosimilar mAbs. Important regulatory requirements for approval of biosimilar products involve comprehensive assessments of any potential differences between proposed biosimilars and reference mAbs, including differences in all known mechanisms of action, using sensitive and relevant methods. Any identified structural differences should not result in differences in biofunctional or clinical activity.\nOBJECTIVE: A comprehensive assessment comparing the Amgen biosimilar candidate ABP\u00a0501 with FDA-licensed adalimumab (adalimumab [US]) and EU-authorized adalimumab (adalimumab [EU]) was conducted to demonstrate similarity in biofunctional activity.\nMETHODS: The functional similarity assessment included testing of binding kinetics to soluble tumor necrosis factor \u03b1 (TNF\u03b1) and relative binding to transmembrane TNF\u03b1. The neutralization of TNF\u03b1-induced caspase activation, TNF\u03b1- and lymphotoxin-\u03b1 (LT\u03b1)-induced chemokine production, and cytotoxicity was also tested. Binding to Fc-gamma receptors Fc\u03b3RIa, Fc\u03b3RIIa (131H), Fc\u03b3RIIIa (158V and 158F), and neonatal Fc receptor (FcRn) was compared with the reference mAbs, as was antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity.\nRESULTS: The data demonstrate that ABP\u00a0501 is similar to both adalimumab (US) and adalimumab (EU) with respect to evaluated biofunctional activities.\nCONCLUSION: Similarity in biofunctional activity is a critical component of the totality of evidence required for demonstration of biosimilarity. The functional similarity demonstrated for ABP\u00a0501 comprehensively assesses the known mechanisms of action of adalimumab, supporting the conclusion that ABP\u00a0501, adalimumab (US), and adalimumab (EU) are likely to be clinically similar.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s40259-016-0185-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1111842", 
        "issn": [
          "1173-8804", 
          "1179-190X"
        ], 
        "name": "BioDrugs", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "30"
      }
    ], 
    "name": "Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab", 
    "pagination": "339-351", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ca45ff14dab230c932c2e0bbde1e12d38352961b3b89bdeb3c3d104006af08d3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27422671"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9705305"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40259-016-0185-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042463549"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40259-016-0185-2", 
      "https://app.dimensions.ai/details/publication/pub.1042463549"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70027_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs40259-016-0185-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40259-016-0185-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40259-016-0185-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40259-016-0185-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40259-016-0185-2'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      21 PREDICATES      66 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40259-016-0185-2 schema:about N279e28a112424c15bc8ecb8987490fb6
2 N4f7993649d26410790d20c1f00604a5b
3 N5038ea0ecb69438899c7b93ac4a7ea7a
4 N51ca8d4ffe69449b9ba56b2ff34ad70e
5 N541e3f0137564861b817adba1a7a32ca
6 N8ab4c66fb6164ee1ad898b0ca4fbeabc
7 N8b15e3a19d304de8a0eb13ae26a1319e
8 N9c8c131832044ae7bb9716d48ab49aa0
9 Nb9a77640ac60418e9f40351fc33aa345
10 Nc1f274224c8944ef827a8a069c51b8bf
11 Nc463bafc88754cb086ce99ae3a2f5806
12 Ndf597128f4bb4675a683ca20446d29a6
13 Ne9525fd29490401d905c3c493d4ef091
14 anzsrc-for:11
15 anzsrc-for:1107
16 schema:author Nd16693b92a4748d3b2704be87032eb2e
17 schema:citation sg:pub.10.1007/s40259-016-0184-3
18 sg:pub.10.1038/nrd2804
19 sg:pub.10.1038/sj.jidsymp.5650034
20 https://doi.org/10.1002/art.23447
21 https://doi.org/10.1002/ibd.20225
22 https://doi.org/10.1006/abio.2001.5380
23 https://doi.org/10.1016/j.biologicals.2014.05.005
24 https://doi.org/10.1016/j.crohns.2014.02.007
25 https://doi.org/10.1016/j.cyto.2008.11.008
26 https://doi.org/10.1016/j.jaad.2016.02.972
27 https://doi.org/10.1016/j.pharmthera.2007.10.001
28 https://doi.org/10.1016/s1074-7613(00)80152-1
29 https://doi.org/10.1053/j.gastro.2014.10.011
30 https://doi.org/10.1089/blr.2006.25.447
31 https://doi.org/10.1093/rheumatology/keq031
32 https://doi.org/10.1097/mib.0b013e318281333b
33 https://doi.org/10.1111/apt.12749
34 https://doi.org/10.1136/annrheumdis-2014-eular.2166
35 https://doi.org/10.1136/annrheumdis-2015-208914
36 https://doi.org/10.1182/blood-2014-06-583617
37 https://doi.org/10.2147/bs.s75573
38 https://doi.org/10.4049/jimmunol.1003526
39 https://doi.org/10.4236/abb.2013.44a004
40 https://doi.org/10.6004/jnccn.2011.0136
41 schema:datePublished 2016-08
42 schema:datePublishedReg 2016-08-01
43 schema:description BACKGROUND: Due to the complex molecular structure and proprietary manufacturing processes of monoclonal antibodies (mAbs), differences in structure and function may be expected during development of biosimilar mAbs. Important regulatory requirements for approval of biosimilar products involve comprehensive assessments of any potential differences between proposed biosimilars and reference mAbs, including differences in all known mechanisms of action, using sensitive and relevant methods. Any identified structural differences should not result in differences in biofunctional or clinical activity. OBJECTIVE: A comprehensive assessment comparing the Amgen biosimilar candidate ABP 501 with FDA-licensed adalimumab (adalimumab [US]) and EU-authorized adalimumab (adalimumab [EU]) was conducted to demonstrate similarity in biofunctional activity. METHODS: The functional similarity assessment included testing of binding kinetics to soluble tumor necrosis factor α (TNFα) and relative binding to transmembrane TNFα. The neutralization of TNFα-induced caspase activation, TNFα- and lymphotoxin-α (LTα)-induced chemokine production, and cytotoxicity was also tested. Binding to Fc-gamma receptors FcγRIa, FcγRIIa (131H), FcγRIIIa (158V and 158F), and neonatal Fc receptor (FcRn) was compared with the reference mAbs, as was antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity. RESULTS: The data demonstrate that ABP 501 is similar to both adalimumab (US) and adalimumab (EU) with respect to evaluated biofunctional activities. CONCLUSION: Similarity in biofunctional activity is a critical component of the totality of evidence required for demonstration of biosimilarity. The functional similarity demonstrated for ABP 501 comprehensively assesses the known mechanisms of action of adalimumab, supporting the conclusion that ABP 501, adalimumab (US), and adalimumab (EU) are likely to be clinically similar.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree true
47 schema:isPartOf N9c1973dc2661418fa6ebdb88e9801f0b
48 Nc66f292ae2b648598a50608cc53d70ad
49 sg:journal.1111842
50 schema:name Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab
51 schema:pagination 339-351
52 schema:productId N1089a5dd819a42f78e67787ca36d4fb4
53 N335719ca137f4c009c72127473676f01
54 N8dd925ca2a4a4d20be99f1b097f43ee2
55 N9092799da3644b4cacb2d4598a3fb42d
56 Nf549bfd680604cbfacb4a20ec6346cb0
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042463549
58 https://doi.org/10.1007/s40259-016-0185-2
59 schema:sdDatePublished 2019-04-11T12:35
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher Naf73fb09e68d4cf7beab5aa243567031
62 schema:url https://link.springer.com/10.1007%2Fs40259-016-0185-2
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N1089a5dd819a42f78e67787ca36d4fb4 schema:name doi
67 schema:value 10.1007/s40259-016-0185-2
68 rdf:type schema:PropertyValue
69 N1d48b9957b2e42f381874a8f6df67039 rdf:first Nf12a8817189849a693c045542777a5be
70 rdf:rest Nd2d083aae07f475ab6b07aa98ddcf60b
71 N279e28a112424c15bc8ecb8987490fb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Cricetulus
73 rdf:type schema:DefinedTerm
74 N335719ca137f4c009c72127473676f01 schema:name nlm_unique_id
75 schema:value 9705305
76 rdf:type schema:PropertyValue
77 N4f7993649d26410790d20c1f00604a5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Antibody-Dependent Cell Cytotoxicity
79 rdf:type schema:DefinedTerm
80 N5038ea0ecb69438899c7b93ac4a7ea7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Histocompatibility Antigens Class I
82 rdf:type schema:DefinedTerm
83 N51ca8d4ffe69449b9ba56b2ff34ad70e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Animals
85 rdf:type schema:DefinedTerm
86 N541e3f0137564861b817adba1a7a32ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Humans
88 rdf:type schema:DefinedTerm
89 N5f90306b8f724d828c923cc0a89f2b4f schema:affiliation https://www.grid.ac/institutes/grid.417886.4
90 schema:familyName Brown
91 schema:givenName Ryan
92 rdf:type schema:Person
93 N86254aaecaa64be5a709d0433160402c rdf:first Nf7f4d79a7c5b4618930f9983d807045f
94 rdf:rest Nbd0b5ea093484a37a6723968b2aae372
95 N8ab4c66fb6164ee1ad898b0ca4fbeabc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Adalimumab
97 rdf:type schema:DefinedTerm
98 N8b15e3a19d304de8a0eb13ae26a1319e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name CHO Cells
100 rdf:type schema:DefinedTerm
101 N8dd925ca2a4a4d20be99f1b097f43ee2 schema:name readcube_id
102 schema:value ca45ff14dab230c932c2e0bbde1e12d38352961b3b89bdeb3c3d104006af08d3
103 rdf:type schema:PropertyValue
104 N9092799da3644b4cacb2d4598a3fb42d schema:name dimensions_id
105 schema:value pub.1042463549
106 rdf:type schema:PropertyValue
107 N9aed4a6b0ddd4e3b9c350f49feb326ef rdf:first sg:person.014172554655.08
108 rdf:rest rdf:nil
109 N9c1973dc2661418fa6ebdb88e9801f0b schema:issueNumber 4
110 rdf:type schema:PublicationIssue
111 N9c8c131832044ae7bb9716d48ab49aa0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Lymphotoxin-alpha
113 rdf:type schema:DefinedTerm
114 Naf73fb09e68d4cf7beab5aa243567031 schema:name Springer Nature - SN SciGraph project
115 rdf:type schema:Organization
116 Nb9a77640ac60418e9f40351fc33aa345 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Receptors, Fc
118 rdf:type schema:DefinedTerm
119 Nbd0b5ea093484a37a6723968b2aae372 rdf:first sg:person.01367737005.73
120 rdf:rest Ndbe132cbfb614f25a91859bcc3f61272
121 Nc1f274224c8944ef827a8a069c51b8bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Surface Plasmon Resonance
123 rdf:type schema:DefinedTerm
124 Nc463bafc88754cb086ce99ae3a2f5806 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Biosimilar Pharmaceuticals
126 rdf:type schema:DefinedTerm
127 Nc66f292ae2b648598a50608cc53d70ad schema:volumeNumber 30
128 rdf:type schema:PublicationVolume
129 Nd16693b92a4748d3b2704be87032eb2e rdf:first sg:person.01332245460.17
130 rdf:rest N1d48b9957b2e42f381874a8f6df67039
131 Nd2d083aae07f475ab6b07aa98ddcf60b rdf:first sg:person.010407272255.81
132 rdf:rest N86254aaecaa64be5a709d0433160402c
133 Nd5f21dccefad479fb4213c0a7b5d85ee rdf:first N5f90306b8f724d828c923cc0a89f2b4f
134 rdf:rest N9aed4a6b0ddd4e3b9c350f49feb326ef
135 Ndbe132cbfb614f25a91859bcc3f61272 rdf:first sg:person.01307711153.47
136 rdf:rest Nd5f21dccefad479fb4213c0a7b5d85ee
137 Ndf597128f4bb4675a683ca20446d29a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Receptors, IgG
139 rdf:type schema:DefinedTerm
140 Ne9525fd29490401d905c3c493d4ef091 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Tumor Necrosis Factor-alpha
142 rdf:type schema:DefinedTerm
143 Nf12a8817189849a693c045542777a5be schema:affiliation https://www.grid.ac/institutes/grid.417886.4
144 schema:familyName Chen
145 schema:givenName Yuh-feng
146 rdf:type schema:Person
147 Nf549bfd680604cbfacb4a20ec6346cb0 schema:name pubmed_id
148 schema:value 27422671
149 rdf:type schema:PropertyValue
150 Nf7f4d79a7c5b4618930f9983d807045f schema:affiliation https://www.grid.ac/institutes/grid.417886.4
151 schema:familyName Pastula
152 schema:givenName Christina
153 rdf:type schema:Person
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
158 schema:name Immunology
159 rdf:type schema:DefinedTerm
160 sg:journal.1111842 schema:issn 1173-8804
161 1179-190X
162 schema:name BioDrugs
163 rdf:type schema:Periodical
164 sg:person.010407272255.81 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
165 schema:familyName Rohrbach
166 schema:givenName Amanda
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010407272255.81
168 rdf:type schema:Person
169 sg:person.01307711153.47 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
170 schema:familyName Thomas
171 schema:givenName Heather
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307711153.47
173 rdf:type schema:Person
174 sg:person.01332245460.17 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
175 schema:familyName Velayudhan
176 schema:givenName Jyoti
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01332245460.17
178 rdf:type schema:Person
179 sg:person.01367737005.73 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
180 schema:familyName Maher
181 schema:givenName Gwen
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367737005.73
183 rdf:type schema:Person
184 sg:person.014172554655.08 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
185 schema:familyName Born
186 schema:givenName Teresa L.
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014172554655.08
188 rdf:type schema:Person
189 sg:pub.10.1007/s40259-016-0184-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038300105
190 https://doi.org/10.1007/s40259-016-0184-3
191 rdf:type schema:CreativeWork
192 sg:pub.10.1038/nrd2804 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011803907
193 https://doi.org/10.1038/nrd2804
194 rdf:type schema:CreativeWork
195 sg:pub.10.1038/sj.jidsymp.5650034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038176817
196 https://doi.org/10.1038/sj.jidsymp.5650034
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1002/art.23447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041038096
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1002/ibd.20225 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023972012
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1006/abio.2001.5380 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010553021
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/j.biologicals.2014.05.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027312444
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/j.crohns.2014.02.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001979414
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/j.cyto.2008.11.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044711621
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/j.jaad.2016.02.972 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041679936
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/j.pharmthera.2007.10.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045852057
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1016/s1074-7613(00)80152-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040583975
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1053/j.gastro.2014.10.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009055890
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1089/blr.2006.25.447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059238419
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/rheumatology/keq031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046888240
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1097/mib.0b013e318281333b schema:sameAs https://app.dimensions.ai/details/publication/pub.1029263183
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1111/apt.12749 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046366682
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1136/annrheumdis-2014-eular.2166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041998525
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1136/annrheumdis-2015-208914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062759425
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1182/blood-2014-06-583617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011903836
231 rdf:type schema:CreativeWork
232 https://doi.org/10.2147/bs.s75573 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004115169
233 rdf:type schema:CreativeWork
234 https://doi.org/10.4049/jimmunol.1003526 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011527870
235 rdf:type schema:CreativeWork
236 https://doi.org/10.4236/abb.2013.44a004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022030812
237 rdf:type schema:CreativeWork
238 https://doi.org/10.6004/jnccn.2011.0136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078459400
239 rdf:type schema:CreativeWork
240 https://www.grid.ac/institutes/grid.417886.4 schema:alternateName Amgen (United States)
241 schema:name Amgen, Inc., One Amgen Center Drive, 91320, Thousand Oaks, CA, USA
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...